Pablo E. Pérgola

Finerenone in hypertensive non-diabetic chronic kidney disease: a FIND-CKD subgroup analysis

Hiddo J.L. Heerspink, Jelle M. Beernink, Rajiv Agarwal, David Z I Cherney et autres

nl, au, us, ca, sg, gr, pt, cn, dk, ar, jp, de, ph (code pays fourni par la source)

Prognostic stratification in a diabetic kidney disease trial using plasma concentrations of soluble tumor necrosis factor receptor 1

Vladimír Petrovič, Vladislav A. Malkov, Andrew N. Billin, Uptal D. Patel et autres

us (code pays fourni par la source)

Global prevalence of elevated high-sensitivity C-reactive protein in patients with atherosclerotic cardiovascular disease, with and without chronic kidney disease: findings from the POSEIDON study

Ann Marie Návar, Ling Bai, Jesper Falkesgaard Højen, Fabrice Ivanes et autres

us, cn, dk, fr, sg, de, gb, it, br, au, ca, jp (code pays fourni par la source)

Finerenone in Patients With Chronic Kidney Disease Due to Glomerular Diseases

Brendon L. Neuen, V Perkovic, Rajiv Agarwal, D Cherney et autres

au, us, ca, sg, de, gr, gb, ch, cn, mx, ru, jp, be, in, hk, nl, es (code pays fourni par la source)

Correction to: Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study

Stuart M. Sprague, Daniel E. Weiner, David P. Tietjen, Pablo E. Pérgola et autres

Chronic Inflammation as an Overlooked Link between Cardiovascular and Kidney Disease

Pablo E. Pérgola, Richard J Johnson, Adeera Levin, Peter Stenvinkel

us, ca, se (code pays fourni par la source)

Abstract 4363200: A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of Monthly or Quarterly Subcutaneous Administration of the Interleukin-6 Inhibitor Pacibekitug in Patients With Elevated High-Sensitivity C-Reactive Protein and Chronic Kidney Disease: 90-Day Analyses from TRANQUILITY

Pablo E. Pérgola, Michael Szarek, Hany Zayed, Famina Hemani et autres

us (code pays fourni par la source)

Balcinrenone in combination with dapagliflozin compared with dapagliflozin alone in patients with chronic kidney disease and albuminuria: a randomised, active-controlled double-blind, phase 2b clinical trial

Hiddo J.L. Heerspink, José Cardona, Shivinder Jolly, Pablo E. Pérgola et autres

nl, us, pl, es, fi, it, gb (code pays fourni par la source)

Narrow Transferrin Saturation and Ferritin Ranges Predict Optimal Hemoglobin Response to IV Iron in Patients with Nondialysis-Dependent CKD

Steven Fishbane, Roberto Pecoits-Filho, Sima Bhatt, Geoffrey A. Block et autres

us, de (code pays fourni par la source)

A Phase 1b, Double-Blind, Placebo-Controlled Study of DISC-0974, an Anti-Hemojuvelin Antibody, in Patients with Nondialysis-Dependent CKD and Anemia

Pablo E. Pérgola, F. David Newby, Vahagn A. Zakaryan, Arnold L. Silva et autres

us (code pays fourni par la source)

Efficacy and Safety of Balcinrenone in Combination with Dapagliflozin on Albuminuria in Participants with CKD

Hiddo Jan L. Heerspink, José F. Cardona, Shivinder Jolly, Pablo E. Pérgola et autres

nl, us, ca, pl, es, se, it, br, gb (code pays fourni par la source)

A Phase 2 Clinical Trial of Oxylanthanum Carbonate in Patients Receiving Maintenance Hemodialysis with Hyperphosphatemia

Geoffrey A. Block, Glenn M. Chertow, G. Lakshma Reddy, Steven J. Hasal et autres

us (code pays fourni par la source)